Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by KayakerBCon Dec 22, 2022 12:56pm
41 Views
Post# 35187436

RE:RE:RE:RE:RE:Biodexa's CEO

RE:RE:RE:RE:RE:Biodexa's CEOMany like a tight float and big spread. It signifies there may not be much available?

Uh, no.  Together with the volume, it signals a total lack of interest.

What happens if Biodexa's CEO announces a J&J deal his Watson and Crick moment(Q-Sphera)? What about a multi-product deal with J&J on xB3? The multi-product option expires just before the anticipated NASDAQ listing. What about with the promotional platform of J&J on two platform technologies Biodexa's CEO again says that he defies anyone to find another biotech of its size and resources with the opportunity? Could the shares spike bigtime? What's Armistice's track record promoting its holdings? It will own much of the stock. 

What happens if this?  What happens if that?  Speculation. Your specialty.  Blah Blah. It's worth nothing.  Hey, what happens if I have my own Watson & Crick moment, make all the right investments and finish up 2023 with $100,000,000 in the bank?  It could happen!  I have the opportunity!


<< Previous
Bullboard Posts
Next >>